The week in science and science policy 11/6/17-11/13/17

By | November 13, 2017

1. The GOP tax bill would significanlty increase taxes on Ph.D. students If you’re tied in at all to science/Ph.D. social media, this was big news last week. The GOP tax bill may end nontaxable tuition waivers for grad students, dramatically increasing the taxes that grad students would have to pay. The end of waivers… Read More »

The week in science and science policy 10/30/17-11/5/17

By | November 6, 2017

1. Sen. Rand Paul’s mission to change federal research proposal peer-review panels Senator Paul proposed a bill that would add two new members to peer-review panels for federal funding applications. One would be an expert in a field unrelated to the research who has not worked in academia for 10 years, while the other would… Read More »

The week in Science and Science Policy 10/22/17-10/29/17

By | October 30, 2017

1. Read this fantastic interview with sociologist/science philosopher Bruno Latour Latour is one of the premier contemporary thinkers examining how we do science and what “science” actually is. While he’s been accused of jeopardizing science and paving the way to science denial (especially in the realms of climate change), this does not make his research… Read More »

Fund Science to Fight Cancer

By | September 7, 2017

This December the United States will enter the 46th year of its longest ongoing war: the war on cancer. During this time, we have lost more lives to this disease than all U.S. military casualties since the birth of our country. The passage of the National Cancer Act in 1971 led to significant advances in… Read More »

Funding is Essential for FDA Oncology Center of Excellence

By | September 5, 2017

In early 2017, the Oncology Center of Excellence (OCE) was established by the U.S. Food and Drug Administration (FDA) to modernize the cancer drug approval process by increasing intra-agency collaboration and promoting novel regulatory ideas and processes. Among critical, medical innovation initiatives, the 21st Century Cures Act (Cures) directed the Agency to create inter-center institutes… Read More »

The week in Science and Science Policy 7/9/17-7/16/17

By | July 17, 2017

1. The importance and future of Fetal Bovine Serum Fetal bovine serum is one of the most common reagents I use in lab every day. As a cancer biologist working with immortalized human and mouse cell lines, it’s a key component of the cell growth media that I feed to my cells to keep them… Read More »

Basket Trials: Accelerating Precision Medicine

By | July 11, 2017

On May 23rd 2017, the cancer research community applauded a landmark accomplishment when for the first time the U.S. Food and Drug Administration (FDA) approved Merck’s pembrolizumabfor use in tumors located in any tissue. While cancers are traditionally organized and treated based on their tissue of origin, tumor sequencing has demonstrated that there are important… Read More »

My picks in Science and Science Policy 7/2/17-7/9/17

By | July 10, 2017

1. Most Americans don’t know there’s a scientific consensus on global warming For someone who is a scientist and generally surrounded by other scientists and like minded individuals, the results discussed in this article are hard to believe. According to a new report, only 13% of American’s know that over 90% of climate scientists have… Read More »